Prescription stimulant consumption in the United States compared with 35 other countries
Marcus A Bachhuber, Ashly E Jordan, Brian J Piper · 2026
Read Prescription stimulant consumption in the United States compared with 35 other countries by Marcus A Bachhuber, Ashly E Jordan, Brian J Piper (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13268762.txt.
Description
Marcus A Bachhuber, Ashly E Jordan, and Brian J Piper compare in 2026 prescription stimulant use in the United States with thirty-five other wealthy countries. Their figures come from 2024 data of an international narcotics board. Stimulants, prescribed mainly for attention disorders, have risen for decades in the United States and jumped further during the pandemic, even causing shortages.
Americans made up about a quarter of the combined population yet consumed about two thirds of the stimulants. Per person, only Iceland used more, and the United States rate was several times the comparison average. Methylphenidate formed a far smaller share of American use than elsewhere. The authors call for research into what these policy and practice gaps mean for health and addiction risk.
Catalog record
| CREATOR | Marcus A Bachhuber, Ashly E Jordan, Brian J Piper |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |